Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation

A synthetic peptide representing the receptor‐binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone format...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 2005-02, Vol.202 (2), p.336-343
Hauptverfasser: Schwartz, Z., Carney, D.H., Crowther, R.S., Ryaby, J.T., Boyan, B.D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 343
container_issue 2
container_start_page 336
container_title Journal of cellular physiology
container_volume 202
creator Schwartz, Z.
Carney, D.H.
Crowther, R.S.
Ryaby, J.T.
Boyan, B.D.
description A synthetic peptide representing the receptor‐binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508‐SP. Proliferation ([3H]‐thymidine incorporation) was examined in pre‐confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]‐sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose‐dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [35S]‐sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH)2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [35S]‐sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]‐sulfate incorporation was evident up to 48 h post‐confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH)2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508‐SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcp.20145
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67309007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67309007</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3965-d6c3b31c967e9c7176a2e795f36414121ce56d9403491977d2a5199239d162c43</originalsourceid><addsrcrecordid>eNp1kcGO0zAQhi0EYsvCgRdAPiH2kF07tuP1ERW2gCooUhFHy7UnjXeTODiuSl-OZ8NpC5w4eUb-_288_hF6Sck1JaS8ubfDdUkoF4_QjBIlC16J8jGa5TtaKMHpBXo2jveEEKUYe4ouqBCM31Zshn6tmxi6je_xAEPyDvCb9UqQ2yucIpjUQZ9wqHE0CW9j2KcGD61JgK2Jybdmmyto2xEPmRISHIvW15ANPvTY9A5HSJkydRmUmuxoQu9isIfkLR4a6EM6DID3jW8Bb9pgH3y_xQli53vTYuhdOFly43yd4RPvOOA5elKbdoQX5_MSfbt7v55_KJZfFh_nb5eFZaoShass2zBqVSVBWUllZUqQStSs4pTTkloQlVOcMK6oktKVRlClSqYcrUrL2SV6feLm9X7sYEy68-O0uekh7EZdSUYUITILr05CG8M4Rqj1EH1n4kFToqewdA5LH8PK2ldn6G7TgfunPKeTBTcnwT7_zOH_JP1pvvqDLE4OPyb4-ddh4sP0RCn0988LvVq-u_vKFytN2W9ER7E5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67309007</pqid></control><display><type>article</type><title>Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Schwartz, Z. ; Carney, D.H. ; Crowther, R.S. ; Ryaby, J.T. ; Boyan, B.D.</creator><creatorcontrib>Schwartz, Z. ; Carney, D.H. ; Crowther, R.S. ; Ryaby, J.T. ; Boyan, B.D.</creatorcontrib><description>A synthetic peptide representing the receptor‐binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508‐SP. Proliferation ([3H]‐thymidine incorporation) was examined in pre‐confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]‐sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose‐dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [35S]‐sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH)2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [35S]‐sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]‐sulfate incorporation was evident up to 48 h post‐confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH)2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508‐SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.20145</identifier><identifier>PMID: 15534863</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>24,25-Dihydroxyvitamin D 3 - pharmacology ; Alkaline Phosphatase - antagonists &amp; inhibitors ; Alkaline Phosphatase - metabolism ; Animals ; Cell Differentiation - drug effects ; Cell Division - drug effects ; Cells, Cultured ; Chondrocytes - cytology ; Chondrocytes - physiology ; DNA - biosynthesis ; Dose-Response Relationship, Drug ; Growth Plate - cytology ; Growth Plate - physiology ; Male ; Peptide Fragments - administration &amp; dosage ; Peptide Fragments - pharmacology ; Phenotype ; Proteoglycans - biosynthesis ; Rats ; Rats, Sprague-Dawley ; Ribs ; Sulfates - metabolism ; Thrombin - administration &amp; dosage ; Thrombin - pharmacology ; Time Factors</subject><ispartof>Journal of cellular physiology, 2005-02, Vol.202 (2), p.336-343</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3965-d6c3b31c967e9c7176a2e795f36414121ce56d9403491977d2a5199239d162c43</citedby><cites>FETCH-LOGICAL-c3965-d6c3b31c967e9c7176a2e795f36414121ce56d9403491977d2a5199239d162c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcp.20145$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcp.20145$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15534863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwartz, Z.</creatorcontrib><creatorcontrib>Carney, D.H.</creatorcontrib><creatorcontrib>Crowther, R.S.</creatorcontrib><creatorcontrib>Ryaby, J.T.</creatorcontrib><creatorcontrib>Boyan, B.D.</creatorcontrib><title>Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation</title><title>Journal of cellular physiology</title><addtitle>J. Cell. Physiol</addtitle><description>A synthetic peptide representing the receptor‐binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508‐SP. Proliferation ([3H]‐thymidine incorporation) was examined in pre‐confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]‐sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose‐dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [35S]‐sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH)2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [35S]‐sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]‐sulfate incorporation was evident up to 48 h post‐confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH)2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508‐SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells. © 2004 Wiley‐Liss, Inc.</description><subject>24,25-Dihydroxyvitamin D 3 - pharmacology</subject><subject>Alkaline Phosphatase - antagonists &amp; inhibitors</subject><subject>Alkaline Phosphatase - metabolism</subject><subject>Animals</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Division - drug effects</subject><subject>Cells, Cultured</subject><subject>Chondrocytes - cytology</subject><subject>Chondrocytes - physiology</subject><subject>DNA - biosynthesis</subject><subject>Dose-Response Relationship, Drug</subject><subject>Growth Plate - cytology</subject><subject>Growth Plate - physiology</subject><subject>Male</subject><subject>Peptide Fragments - administration &amp; dosage</subject><subject>Peptide Fragments - pharmacology</subject><subject>Phenotype</subject><subject>Proteoglycans - biosynthesis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Ribs</subject><subject>Sulfates - metabolism</subject><subject>Thrombin - administration &amp; dosage</subject><subject>Thrombin - pharmacology</subject><subject>Time Factors</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcGO0zAQhi0EYsvCgRdAPiH2kF07tuP1ERW2gCooUhFHy7UnjXeTODiuSl-OZ8NpC5w4eUb-_288_hF6Sck1JaS8ubfDdUkoF4_QjBIlC16J8jGa5TtaKMHpBXo2jveEEKUYe4ouqBCM31Zshn6tmxi6je_xAEPyDvCb9UqQ2yucIpjUQZ9wqHE0CW9j2KcGD61JgK2Jybdmmyto2xEPmRISHIvW15ANPvTY9A5HSJkydRmUmuxoQu9isIfkLR4a6EM6DID3jW8Bb9pgH3y_xQli53vTYuhdOFly43yd4RPvOOA5elKbdoQX5_MSfbt7v55_KJZfFh_nb5eFZaoShass2zBqVSVBWUllZUqQStSs4pTTkloQlVOcMK6oktKVRlClSqYcrUrL2SV6feLm9X7sYEy68-O0uekh7EZdSUYUITILr05CG8M4Rqj1EH1n4kFToqewdA5LH8PK2ldn6G7TgfunPKeTBTcnwT7_zOH_JP1pvvqDLE4OPyb4-ddh4sP0RCn0988LvVq-u_vKFytN2W9ER7E5</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Schwartz, Z.</creator><creator>Carney, D.H.</creator><creator>Crowther, R.S.</creator><creator>Ryaby, J.T.</creator><creator>Boyan, B.D.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation</title><author>Schwartz, Z. ; Carney, D.H. ; Crowther, R.S. ; Ryaby, J.T. ; Boyan, B.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3965-d6c3b31c967e9c7176a2e795f36414121ce56d9403491977d2a5199239d162c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>24,25-Dihydroxyvitamin D 3 - pharmacology</topic><topic>Alkaline Phosphatase - antagonists &amp; inhibitors</topic><topic>Alkaline Phosphatase - metabolism</topic><topic>Animals</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Division - drug effects</topic><topic>Cells, Cultured</topic><topic>Chondrocytes - cytology</topic><topic>Chondrocytes - physiology</topic><topic>DNA - biosynthesis</topic><topic>Dose-Response Relationship, Drug</topic><topic>Growth Plate - cytology</topic><topic>Growth Plate - physiology</topic><topic>Male</topic><topic>Peptide Fragments - administration &amp; dosage</topic><topic>Peptide Fragments - pharmacology</topic><topic>Phenotype</topic><topic>Proteoglycans - biosynthesis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Ribs</topic><topic>Sulfates - metabolism</topic><topic>Thrombin - administration &amp; dosage</topic><topic>Thrombin - pharmacology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartz, Z.</creatorcontrib><creatorcontrib>Carney, D.H.</creatorcontrib><creatorcontrib>Crowther, R.S.</creatorcontrib><creatorcontrib>Ryaby, J.T.</creatorcontrib><creatorcontrib>Boyan, B.D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartz, Z.</au><au>Carney, D.H.</au><au>Crowther, R.S.</au><au>Ryaby, J.T.</au><au>Boyan, B.D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J. Cell. Physiol</addtitle><date>2005-02</date><risdate>2005</risdate><volume>202</volume><issue>2</issue><spage>336</spage><epage>343</epage><pages>336-343</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><abstract>A synthetic peptide representing the receptor‐binding domain of human thrombin (TP508, also known as Chrysalin®) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 μg/ml TP508 or a scrambled peptide, TP508‐SP. Proliferation ([3H]‐thymidine incorporation) was examined in pre‐confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]‐sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose‐dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [35S]‐sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1α,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH)2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [35S]‐sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1α,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]‐sulfate incorporation was evident up to 48 h post‐confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1α,25(OH)2D3, and cultures treated with TP508 followed by 1α,25(OH)2D3. TP508‐SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15534863</pmid><doi>10.1002/jcp.20145</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 2005-02, Vol.202 (2), p.336-343
issn 0021-9541
1097-4652
language eng
recordid cdi_proquest_miscellaneous_67309007
source MEDLINE; Wiley Online Library Journals
subjects 24,25-Dihydroxyvitamin D 3 - pharmacology
Alkaline Phosphatase - antagonists & inhibitors
Alkaline Phosphatase - metabolism
Animals
Cell Differentiation - drug effects
Cell Division - drug effects
Cells, Cultured
Chondrocytes - cytology
Chondrocytes - physiology
DNA - biosynthesis
Dose-Response Relationship, Drug
Growth Plate - cytology
Growth Plate - physiology
Male
Peptide Fragments - administration & dosage
Peptide Fragments - pharmacology
Phenotype
Proteoglycans - biosynthesis
Rats
Rats, Sprague-Dawley
Ribs
Sulfates - metabolism
Thrombin - administration & dosage
Thrombin - pharmacology
Time Factors
title Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-29T18%3A34%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thrombin%20peptide%20(TP508)%20treatment%20of%20rat%20growth%20plate%20cartilage%20cells%20promotes%20proliferation%20and%20retention%20of%20the%20chondrocytic%20phenotype%20while%20blocking%20terminal%20endochondral%20differentiation&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Schwartz,%20Z.&rft.date=2005-02&rft.volume=202&rft.issue=2&rft.spage=336&rft.epage=343&rft.pages=336-343&rft.issn=0021-9541&rft.eissn=1097-4652&rft_id=info:doi/10.1002/jcp.20145&rft_dat=%3Cproquest_cross%3E67309007%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67309007&rft_id=info:pmid/15534863&rfr_iscdi=true